Compare

Outset Medical, Inc. vs Axogen, Inc. vs Iridex Corp vs electroCore, Inc.

Latest annual figures from SEC filings. Each company is shown for its own most recent fiscal year, so period ends can differ. Select a figure to see its full history.

Latest fiscal yearOutset Medical, Inc.
OM
Axogen, Inc.
AXGN
Iridex Corp
IRIX
electroCore, Inc.
ECOR
Year ended2025-12-312025-12-312026-01-032025-12-31
Revenue$119.48M$225.21M$52.67M$32.03M
Revenue growth (YoY)+5.1%+20.2%+8.2%+27.2%
Gross margin39.1%74.3%36.5%86.8%
Operating margin-55.8%-3.5%-4.9%-41.1%
Net margin-68.3%-7.0%-8.4%-43.6%
Net income-$81.65M-$15.70M-$4.44M-$13.97M
EPS (Diluted)-$5.37-$0.34-$0.26-$1.65
Operating cash flow-$46.33M$812.0K-$2.12M-$8.19M
Free cash flow-$47.12M-$2.93M-$2.26M-$8.25M
Cash & equivalents$35.01M$35.55M$6.03M$7.04M
Total assets$264.50M$221.69M$29.15M$18.67M
Total liabilities$137.54M$92.84M$24.23M$20.38M
Shareholders' equity$126.95M$128.85M$4.92M-$1.71M
Return on year-end equity-64.3%-12.2%-90.1%n/a
Shares outstanding18.17M47.20M17.31M8.00M

n/a means the company did not report that line under the concept TickerFacts maps, not that it is zero.

Revenue, most recent five fiscal years

Fiscal yearOutset Medical, Inc.Axogen, Inc.Iridex CorpelectroCore, Inc.
Latest$119.48M
Ended 2025-12-31
$225.21M
Ended 2025-12-31
$52.67M
Ended 2026-01-03
$32.03M
Ended 2025-12-31
1 year earlier$113.69M
Ended 2024-12-31
$187.34M
Ended 2024-12-31
$48.67M
Ended 2024-12-28
$25.18M
Ended 2024-12-31
2 years earlier$130.38M
Ended 2023-12-31
$159.01M
Ended 2023-12-31
$51.87M
Ended 2023-12-30
$16.03M
Ended 2023-12-31
3 years earlier$115.38M
Ended 2022-12-31
$138.58M
Ended 2022-12-31
$56.97M
Ended 2022-12-31
$8.59M
Ended 2022-12-31
4 years earlier$102.60M
Ended 2021-12-31
$127.36M
Ended 2021-12-31
$53.90M
Ended 2022-01-01
$5.45M
Ended 2021-12-31